{"id":"https://openalex.org/W821449864","doi":null,"title":"Aliskiren \u2013 pierwszy przedstawiciel nowej grupy lek\u00f3w hipotensyjnych","display_name":"Aliskiren \u2013 pierwszy przedstawiciel nowej grupy lek\u00f3w hipotensyjnych","publication_year":2009,"publication_date":"2009-09-01","ids":{"openalex":"https://openalex.org/W821449864","mag":"821449864"},"language":"pl","primary_location":{"id":"pmh:oai:doaj.org/article:837941c805a9488ca0ae2936d8ca8611","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/837941c805a9488ca0ae2936d8ca8611","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Pediatria i Medycyna Rodzinna, Vol 5, Iss 2, Pp 80-82 (2009)","raw_type":"article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["doaj"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://doaj.org/article/837941c805a9488ca0ae2936d8ca8611","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5023781295","display_name":"Katarzyna Jobs","orcid":"https://orcid.org/0000-0002-8616-2347","observed_orcids":["https://orcid.org/0000-0002-8616-2347"]},"institutions":[{"id":"https://openalex.org/I4210146974","display_name":"Wojskowy Instytut Medyczny","ror":"https://ror.org/04zvqhj72","country_code":"PL","type":"healthcare","lineage":["https://openalex.org/I4210146974"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Katarzyna Job","raw_affiliation_strings":["Klinika Pediatrii, Nefrologii i Alergologii Dzieci\u0119cej Wojskowego Instytutu Medycznego w Warszawie. Kierownik Kliniki: prof. dr hab. n. med. Anna Jung"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Klinika Pediatrii, Nefrologii i Alergologii Dzieci\u0119cej Wojskowego Instytutu Medycznego w Warszawie. Kierownik Kliniki: prof. dr hab. n. med. Anna Jung","institution_ids":["https://openalex.org/I4210146974"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5027554762","display_name":"Anna Jung","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210146974","display_name":"Wojskowy Instytut Medyczny","ror":"https://ror.org/04zvqhj72","country_code":"PL","type":"healthcare","lineage":["https://openalex.org/I4210146974"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Anna Jung","raw_affiliation_strings":["Klinika Pediatrii, Nefrologii i Alergologii Dzieci\u0119cej Wojskowego Instytutu Medycznego w Warszawie. Kierownik Kliniki: prof. dr hab. n. med. Anna Jung"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Klinika Pediatrii, Nefrologii i Alergologii Dzieci\u0119cej Wojskowego Instytutu Medycznego w Warszawie. Kierownik Kliniki: prof. dr hab. n. med. Anna Jung","institution_ids":["https://openalex.org/I4210146974"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210146974"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11001","display_name":"Renin-Angiotensin System Studies","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11001","display_name":"Renin-Angiotensin System Studies","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.0017999999690800905,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11917","display_name":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/aliskiren","display_name":"aliskiren","score":0.9980000257492065},{"id":"https://openalex.org/keywords/renin-inhibitors","display_name":"renin inhibitors","score":0.9169999957084656},{"id":"https://openalex.org/keywords/hypertension","display_name":"hypertension","score":0.7440000176429749},{"id":"https://openalex.org/keywords/essential-hypertension","display_name":"essential hypertension","score":0.6690000295639038},{"id":"https://openalex.org/keywords/renin-angiotensin-system","display_name":"renin-angiotensin system","score":0.8349999785423279},{"id":"https://openalex.org/keywords/angiotensinogen","display_name":"angiotensinogen","score":0.6980000138282776},{"id":"https://openalex.org/keywords/ace-inhibitors","display_name":"ACE inhibitors","score":0.6470000147819519},{"id":"https://openalex.org/keywords/angiotensin-receptor-blockers","display_name":"angiotensin receptor blockers","score":0.9139999747276306},{"id":"https://openalex.org/keywords/renal-protection","display_name":"renal protection","score":0.7990000247955322},{"id":"https://openalex.org/keywords/cardioprotection","display_name":"cardioprotection","score":0.9829999804496765},{"id":"https://openalex.org/keywords/oral-bioavailability","display_name":"oral bioavailability","score":0.8529999852180481},{"id":"https://openalex.org/keywords/adverse-effects","display_name":"adverse effects","score":0.6880000233650208},{"id":"https://openalex.org/keywords/history-of-drug-development","display_name":"drug development history","score":0.39399999380111694},{"id":"https://openalex.org/keywords/combination-antihypertensive-therapy","display_name":"combination antihypertensive therapy","score":0.6790000200271606},{"id":"https://openalex.org/keywords/blood-pressure","display_name":"blood pressure","score":0.44600000977516174}],"concepts":[{"id":"https://openalex.org/C2779838083","wikidata":"https://www.wikidata.org/wiki/Q414904","display_name":"Aliskiren","level":4,"score":0.8578026294708252},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2708480954170227},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.24955761432647705},{"id":"https://openalex.org/C198710026","wikidata":"https://www.wikidata.org/wiki/Q898218","display_name":"Renin\u2013angiotensin system","level":3,"score":0.05626720190048218},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"pmh:oai:doaj.org/article:837941c805a9488ca0ae2936d8ca8611","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/837941c805a9488ca0ae2936d8ca8611","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Pediatria i Medycyna Rodzinna, Vol 5, Iss 2, Pp 80-82 (2009)","raw_type":"article"}],"best_oa_location":{"id":"pmh:oai:doaj.org/article:837941c805a9488ca0ae2936d8ca8611","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/837941c805a9488ca0ae2936d8ca8611","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Pediatria i Medycyna Rodzinna, Vol 5, Iss 2, Pp 80-82 (2009)","raw_type":"article"},"sustainable_development_goals":[{"score":0.9537000060081482,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":7,"referenced_works":["https://openalex.org/W75251984","https://openalex.org/W147860503","https://openalex.org/W2063358281","https://openalex.org/W2137177722","https://openalex.org/W2145632481","https://openalex.org/W2170271198","https://openalex.org/W2171818587"],"related_works":["https://openalex.org/W4242834615","https://openalex.org/W2086448255","https://openalex.org/W2593168705","https://openalex.org/W2905549373","https://openalex.org/W1978958912","https://openalex.org/W2938733039","https://openalex.org/W2584889891","https://openalex.org/W2111355276","https://openalex.org/W295532945","https://openalex.org/W2400490120"],"abstract_inverted_index":{"Aliskiren":[0],"jest":[1,120],"pierwszym":[2],"przedstawicielem":[3],"nowej":[4],"grupy":[5],"lek\u00f3w":[6],"hipotensyjnych":[7],"\u2013":[8],"bezpo\u015brednich":[9],"inhibitor\u00f3w":[10],"reniny.":[11],"Badania":[12],"nad":[13,112],"jego":[14,71,159],"powstaniem":[15],"trwa\u0142y":[16],"d\u0142ugo,":[17],"g\u0142\u00f3wnie":[18],"z":[19,22,70,87,130,151,170,177],"powodu":[20],"trudno\u015bci":[21],"uzyskaniem":[23],"preparatu":[24],"o":[25,51],"dobrej":[26,57],"biodost\u0119pno\u015bci":[27],"formy":[28],"doustnej.":[29],"W":[30],"2007":[31],"roku":[32],"zosta\u0142":[33],"dopuszczony":[34],"do":[35,64,179],"leczenia":[36,133],"pierwotnego":[37],"nadci\u015bnienia":[38],"t\u0119tniczego":[39],"w":[40,83,115,145,149],"Stanach":[41],"Zjednoczonych":[42],"i":[43,56,79,118,137,153,163],"krajach":[44],"Unii":[45],"Europejskiej.":[46],"Jest":[47],"skutecznym":[48],"lekiem":[49],"hipotensyjnym,":[50],"ma\u0142ej":[52],"liczbie":[53],"dzia\u0142a\u0144":[54],"ubocznych":[55],"tolerancji.":[58],"Blokuj\u0105c":[59],"renin\u0119,":[60],"zapobiega":[61],"konwersji":[62],"angiotensynogenu":[63],"angiotensyny":[65,95],"I.":[66],"Pierwsze":[67],"badania":[68],"kliniczne":[69],"wykorzystaniem":[72,113],"daj\u0105":[73],"nadziej\u0119":[74],"na":[75,139,158],"addytywny":[76],"efekt":[77],"hipotensyjny":[78],"nefro-":[80,117],"oraz":[81],"kardioprotekcyjny,":[82],"przypadku":[84],"po\u0142\u0105czenia":[85,103],"go":[86],"inhibitorami":[88],"konwertazy":[89],"(ACEI)":[90],"lub":[91],"antagonistami":[92],"receptora":[93],"dla":[94,102],"II":[96],"(ARB).":[97],"Podobnego":[98],"efektu":[99],"nie":[100],"wykazano":[101],"tycw":[104],"dw\u00f3ch":[105,201],"grup":[106],"lek\u00f3w.":[107],"Najwi\u0119kszym,":[108],"trwaj\u0105cym":[109],"w\u0142a\u015bnie":[110],"badaniem":[111],"aliskirenu":[114],"udoskonaleniu":[116],"kardioprotekcji":[119],"badanie":[121],"ASPIRE":[122],"HIGHER.":[123],"Obejmuje":[124],"ono":[125],"ponad":[126,134],"35":[127],"tysi\u0119cy":[128],"chorych,":[129],"planowanym":[131],"okresem":[132],"6":[135],"lat,":[136],"ma":[138],"celu":[140],"sprawdzenie":[141],"potencjalnej":[142],"wy\u017cszo\u015bci":[143],"leku":[144],"zakresie":[146],"dzia\u0142ania":[147],"nefroprotekcyjnego":[148],"por\u00f3wnaniu":[150],"ACEI":[152],"ARB.":[154],"Wst\u0119pne":[155],"wyniki":[156],"wskazuj\u0105":[157],"du\u017cy":[160],"potencja\u0142":[161],"kardio-":[162],"nefroprotekcyjny.":[164],"Po":[165],"podaniu":[166],"doustnym":[167],"u":[168],"chorych":[169],"nadci\u015bnieniem":[171],"zmniejsza":[172],"on":[173],"aktywno\u015b\u0107":[174],"reninow\u0105":[175],"osocza":[176],"50":[178],"80%.":[180],"Lek":[181],"obni\u017ca":[182],"warto\u015b\u0107":[183],"ci\u015bnienia":[184],"skurczowego":[185],"irozkurczowego,":[186],"a":[187],"dzia\u0142anie":[188,197],"pojedynczej":[189],"dawki":[190],"utrzymuje":[191],"si\u0119":[192],"przez":[193],"24":[194],"godziny.":[195],"Pe\u0142ne":[196],"terapeutyczne":[198],"osi\u0105ga":[199],"po":[200],"tygodniach.":[202]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}